期刊文献+

正确认识细胞形态学在骨髓增生异常综合征诊断中的地位 被引量:7

原文传递
导出
摘要 骨髓增生异常综合征(myelodysplastic symdrome,MDS)是一组起源于造血干细胞的克隆性髓系恶性肿瘤,其特征是外周血细胞计数减少、髓系细胞一系或多系发育异常及无效造血.患者演变为急性髓系白血病(acute myeloid leukemia,AML)的风险增高。
作者 肖志坚
出处 《诊断学理论与实践》 2013年第1期1-3,共3页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献10

二级参考文献21

  • 1郝洪波,肖志坚.不典型骨髓增生异常综合征的诊断[J].白血病.淋巴瘤,2005,14(2):121-123. 被引量:3
  • 2肖志坚.骨髓增生异常综合征的诊断和治疗认识现况[J].国际输血及血液学杂志,2007,30(1):1-4. 被引量:9
  • 3Maciejewski JP, O'Keefe C, Gondek L, et al. Immune-mediated bone marrow failure syndromes of progenitor and stem cells : molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol, 2007,45:5-14.
  • 4Corey SJ, Minden MD, Barber DL, et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer, 2007,7:118-129.
  • 5Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 2006, 108:2509-2519.
  • 6Nosslinger T, Reisner R, Koller E, et al. Myelodysplastic syndromes, from French-American- British to World Health Organization : comparison of classifications on 431 unselected patients from a single institution. Blood,2001,98:2935-2941.
  • 7Tichelll A, Gratwohl A, Nissen C, et al. Morphology in patients with severe aplastie anemia treated with antilymphoeyte globulin. Blood, 1992,80:337- 345.
  • 8Maschek H, Kaloutsi V, Rodrignez-Kaiser M, et al. Hypoplastic myelodysplastic syndrome : incidence, morphology, cytogeneties, and prognosis. Ann Hematol, 1993,66 : 117-122.
  • 9Orazi A, Albitar M, Heerema NA, et al. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol,1997 ,107 :268-274.
  • 10Sakuma T, Hayashi Y, Kanomata N, et al. Histological and eytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes. Pathol Int, 2006, 56:191-199.

共引文献51

同被引文献45

  • 1史杏英.骨髓增生异常综合征58例误诊分析[J].浙江中西医结合杂志,1994,4(2):12-13. 被引量:3
  • 2韩爱兰,杨长春,王艳,陈英.特殊类型骨髓增生异常综合征形态学误诊4例分析[J].中国误诊学杂志,2005,5(10):1898-1899. 被引量:1
  • 3张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,200719-23157-163.
  • 4张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,20071-3.
  • 5李焱;张金巧;杨志霞.血液内科疾病诊断标准[M]北京:科学技术文献出版社,200931.
  • 6Rong W,Cary PG,Kevin F,et al.The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes[J].Leukemia Research,2012,36(11):1370-1375.
  • 7James MF,Jamile MS.Clinical presentation,diagnosis,and prognosis of myelodysplastic syndromes[J].Am J Med,2012,125(7 Suppl):S6-S13.
  • 8Heather AL,Rena B,April S,et al.The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes:A clinical practice guideline[J].Critical Reviews in Oncology/Hematology,2013,85(2):162-192.
  • 9Sa AW,Lynne VA,Robert PH,et al.Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features[J].Leukemia Research,2011,35(3):351-357.
  • 10Elias J,Guillermo GM,Farhad R,et al.Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabine[J].Clinical Lymphoma Myeloma and Leukemia,2013,13(2):131-138.

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部